Recent advances in the management of unstable angina and non-Q-wave myocardial infarction.
作者信息
Steeds R P, Channer K S
机构信息
Department of Cardiology, Royal Hallamshire Hospital, Sheffield.
出版信息
Br J Clin Pharmacol. 1998 Oct;46(4):335-41. doi: 10.1046/j.1365-2125.1998.t01-1-00795.x.
Abstract
摘要
相似文献
1
Recent advances in the management of unstable angina and non-Q-wave myocardial infarction.不稳定型心绞痛和非Q波心肌梗死治疗的最新进展
Br J Clin Pharmacol. 1998 Oct;46(4):335-41. doi: 10.1046/j.1365-2125.1998.t01-1-00795.x.
2
New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarction.不稳定型心绞痛和非ST段抬高型心肌梗死的诊断与管理新方法。
Arch Intern Med. 2001 Mar 12;161(5):674-82. doi: 10.1001/archinte.161.5.674.
3
Beyond heparin and aspirin: new treatments for unstable angina and non-Q-wave myocardial infarction.除肝素和阿司匹林外：不稳定型心绞痛和非Q波心肌梗死的新疗法。
Arch Intern Med. 2000 Mar 27;160(6):749-58. doi: 10.1001/archinte.160.6.749.
4
Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: proposed revisions. International Cardiology Forum.不稳定型心绞痛和非Q波心肌梗死的诊断与管理指南：修订建议。国际心脏病学论坛。
Am Heart J. 2000 Mar;139(3):461-75. doi: 10.1016/s0002-8703(00)90090-5.
5
Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial.C反应蛋白和肌钙蛋白T在不稳定型心绞痛患者中的预测价值：一项对比分析。CAPTURE研究组。嵌合型c7E3抗血小板治疗对标准治疗无效的不稳定型心绞痛试验。
J Am Coll Cardiol. 2000 May;35(6):1535-42. doi: 10.1016/s0735-1097(00)00581-7.
6
Present treatment options for unstable angina and non-Q-wave myocardial infarction.不稳定型心绞痛和非Q波心肌梗死的现有治疗方案。
QJM. 2001 Jan;94(1):5-11. doi: 10.1093/qjmed/94.1.5.
7
Optimal treatment of patients with acute coronary syndromes and non-ST-elevation myocardial infarction.急性冠状动脉综合征和非ST段抬高型心肌梗死患者的最佳治疗
Am Heart J. 1999 Aug;138(2 Pt 2):S105-14. doi: 10.1016/s0002-8703(99)70329-7.
8
ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.美国心脏病学会/美国心脏协会不稳定型心绞痛和非ST段抬高型心肌梗死患者管理指南：执行摘要与推荐意见
Catheter Cardiovasc Interv. 2000 Dec;51(4):505-21. doi: 10.1002/1522-726x(200012)51:4<505::aid-ccd29>3.0.co;2-l.
9
New therapies for unstable angina and non-Q-wave myocardial infarction: recent clinical trials.不稳定型心绞痛和非Q波心肌梗死的新疗法：近期临床试验
Am Heart J. 1998 Jun;135(6 Pt 3 Su):S343-52. doi: 10.1053/hj.1998.v135.90302.
10
Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators.不稳定型心绞痛或非Q波心肌梗死患者冠状动脉内血栓形成及替罗非班对血小板糖蛋白IIb/IIIa受体的阻断作用。PRISM-PLUS试验（对有不稳定体征和症状的患者进行缺血综合征管理的血小板受体抑制试验）的血管造影结果。PRISM-PLUS研究人员。
Circulation. 1999 Oct 12;100(15):1609-15. doi: 10.1161/01.cir.100.15.1609.
本文引用的文献
1
A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina.阿司匹林联合替罗非班与阿司匹林联合肝素治疗不稳定型心绞痛的比较。
N Engl J Med. 1998 May 21;338(21):1498-505. doi: 10.1056/NEJM199805213382103.
2
Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.替罗非班抑制血小板糖蛋白IIb/IIIa受体在不稳定型心绞痛和非Q波心肌梗死中的应用
N Engl J Med. 1998 May 21;338(21):1488-97. doi: 10.1056/NEJM199805213382102.
3
Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research Investigators.退伍军人事务部非Q波心肌梗死院内治疗策略（VANQWISH）试验的设计与基线特征。VANQWISH试验研究人员
J Am Coll Cardiol. 1998 Feb;31(2):312-20. doi: 10.1016/s0735-1097(97)00486-5.
4
Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I.通过快速检测心肌肌钙蛋白T或肌钙蛋白I对急性胸痛患者进行急诊室分诊。
N Engl J Med. 1997 Dec 4;337(23):1648-53. doi: 10.1056/NEJM199712043372302.
5
Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.替罗非班阻断血小板糖蛋白IIb/IIIa对接受冠状动脉成形术的不稳定型心绞痛或急性心肌梗死患者不良心脏事件的影响。RESTORE研究人员。替罗非班对结果和再狭窄的随机疗效研究。
Circulation. 1997 Sep 2;96(5):1445-53. doi: 10.1161/01.cir.96.5.1445.
6
Design and methodology of the PURSUIT trial: evaluating eptifibatide for acute ischemic coronary syndromes. Platelet Glycoprotein IIb-IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.PURSUIT试验的设计与方法：评估依替巴肽用于急性缺血性冠状动脉综合征。不稳定型心绞痛中的血小板糖蛋白IIb-IIIa：使用依替巴肽治疗进行受体抑制。
Am J Cardiol. 1997 Aug 18;80(4A):34B-38B. doi: 10.1016/s0002-9149(97)00575-4.
7
Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation: a pilot study. Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators.两剂重组水蛭素与肝素对非ST段抬高急性心肌缺血患者疗效的比较：一项初步研究。缺血综合征评估策略组织（OASIS）研究者。
Circulation. 1997 Aug 5;96(3):769-77. doi: 10.1161/01.cir.96.3.769.
8
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.低分子量肝素与普通肝素治疗不稳定型冠状动脉疾病的比较。皮下注射依诺肝素治疗非Q波冠状动脉事件研究组的疗效与安全性。
N Engl J Med. 1997 Aug 14;337(7):447-52. doi: 10.1056/NEJM199708143370702.
9
Progression of the culprit lesion in unstable coronary artery disease with warfarin and aspirin versus aspirin alone: preliminary study.华法林与阿司匹林联用对比单用阿司匹林治疗不稳定型冠状动脉疾病时罪犯病变的进展：初步研究
J Am Coll Cardiol. 1997 Aug;30(2):364-9. doi: 10.1016/s0735-1097(97)00153-8.
10
Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic Complications.在接受经皮冠状动脉血运重建术的不稳定型心绞痛患者中，阿昔单抗（c7E3 Fab）通过阻断血小板膜糖蛋白IIb/IIIa受体预防死亡和心肌梗死的证据。EPIC研究人员。7E3预防缺血性并发症的评估。
J Am Coll Cardiol. 1997 Jul;30(1):149-56. doi: 10.1016/s0735-1097(97)00110-1.
Zotero 插件